PhageTB
PhageTB predicts bacteriophage–host interactions to identify suitable phage candidates for phage therapy against pathogenic and antibiotic-resistant bacteria.
Key Features:
- Multilevel Prediction Methodology: Integrates alignment-based and alignment-free features derived from genome sequences of bacteriophages and their hosts to enable predictions across multiple taxonomic levels.
- Alignment-Based Models: Utilizes similarity metrics BLASTPhage (phage-phage), BLASTHost (host-host), and CRISPRPred (phage-CRISPR), achieving accuracies ranging from 42.4% to 80.2% across five taxonomic levels.
- Alignment-Free Models: Constructs machine learning-based alignment-free models that capture sequence patterns without relying on sequence similarity.
- Hybrid Models: Integrates alignment-free model outputs with similarity scores from alignment-based approaches to improve prediction performance, achieving accuracies between 60.6% and 93.5%.
- Ensemble Model: Combines hybrid and alignment-based models to yield accuracies of 67.9%, 80.6%, 85.5%, 90%, and 93.5% at Genus, Family, Order, Class, and Phylum levels, respectively.
Scientific Applications:
- Phage therapy candidate identification: Facilitates identification of potential bacteriophage candidates for treating bacterial infections, including antibiotic-resistant strains.
- Taxonomic-level host prediction: Provides host assignment across Genus, Family, Order, Class, and Phylum levels to inform targeted phage selection.
Methodology:
Integrates alignment-based methods (BLASTPhage, BLASTHost, CRISPRPred) and alignment-free machine learning features derived from genome sequences; hybrid models combine alignment-free outputs with similarity scores and an ensemble integrates hybrid and alignment-based models; trained on 826 phage–host interactions and evaluated on a validation set of 1,201 interactions.
Details
- Added:
- 7/24/2024
- Last Updated:
- 11/24/2024
Operations
Publications
Aggarwal S, Dhall A, Patiyal S, Choudhury S, Arora A, Raghava GPS. An ensemble method for prediction of phage-based therapy against bacterial infections. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1148579. PMID:37032893. PMCID:PMC10076811.